Aileron Therapeutics, Inc. (ALRN) Financials

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$0
Day's range
$0

ALRN Income statement / Annual

Last year (2025), 's total revenue was $0.00, and the percentage change from the previous year is not available. In 2025, 's net income was -$49.87 M. See ,s key income statements, including revenue, expenses, profit, and income.

Period FY-2025 FY-2024 FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016
Period Ended 12/31/2025 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016
Operating Revenue $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Cost of Revenue $0.00 $0.00 $119.00 K $169.00 K $121.00 K $163.00 K $155.00 K $218.00 K $95.00 K $232.00 K
Gross Profit $0.00 $0.00 -$119.00 K -$169.00 K -$121.00 K -$163.00 K -$155.00 K -$218.00 K -$95.00 K -$232.00 K
Gross Profit Ratio 0 0 0 0 0 0 0 0 0 0
Research and Development Expenses $11.03 M $14.25 M $3.99 M $17.97 M $17.01 M $11.17 M $17.66 M $18.45 M $14.24 M $10.28 M
General & Administrative Expenses $10.90 M $13.86 M $11.36 M $9.68 M $9.60 M $9.33 M $12.29 M $13.45 M $8.77 M $7.89 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $10.90 M $13.86 M $11.36 M $9.68 M $9.60 M $9.33 M $12.29 M $13.45 M $8.77 M $7.89 M
Other Expenses $28.70 M $37.00 M $928.00 K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -$18.17 M
Operating Expenses $50.63 M $65.11 M $16.28 M $27.65 M $26.61 M $20.50 M $29.96 M $31.90 M $23.01 M $18.17 M
Cost And Expenses $0.00 $0.00 $16.28 M $27.65 M $26.61 M $20.50 M $29.96 M $31.90 M $23.01 M $18.17 M
Interest Income $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $587.00 K $355.00 K $404.00 K $46.00 K
Interest Expense $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Depreciation & Amortization $0.00 $0.00 $119.00 K $169.00 K $121.00 K $163.00 K $155.00 K $218.00 K $95.00 K $232.00 K
EBITDA -$50.63 M -$65.11 M -$15.61 M -$27.48 M -$26.48 M -$20.33 M -$29.80 M -$31.33 M -$23.01 M -$17.94 M
EBITDA Ratio 0 0 0 0 0 0 0 0 0 0
Operating Income Ratio 0 0 0 0 0 0 0 0 0 0
Total Other Income/Expenses Net $760.00 K $2.23 M $544.00 K $318.00 K $441.00 K -$661.00 K $587.00 K $355.00 K $404.00 K $46.00 K
Income Before Tax -$49.87 M -$62.88 M -$15.73 M -$27.33 M -$26.21 M -$21.16 M -$29.37 M -$31.55 M -$22.60 M -$18.12 M
Income Before Tax Ratio 0 0 0 0 0 0 0 0 0 0
Income Tax Expense $0.00 $0.00 $0.00 $0.00 -$441.00 K $0.00 $0.00 $0.00 $34.00 K $0.00
Net Income -$49.87 M -$62.88 M -$15.73 M -$27.01 M -$25.76 M -$21.82 M -$28.78 M -$31.55 M -$22.60 M -$18.12 M
Net Income Ratio 0 0 0 0 0 0 0 0 0 0
EPS -1.96 -3.51 -3.42 -5.95 -5.8 -12.52 -23.46 -42.81 -30.7 -33.21
EPS Diluted -1.96 -3.51 -3.42 -5.95 -5.8 -12.52 -23.46 -42.81 -30.7 -33.21
Weighted Average Shares Out $25.44 M $17.94 M $4.60 M $4.54 M $4.44 M $1.74 M $1.23 M $736.91 K $736.40 K $545.72 K
Weighted Average Shares Out Diluted $25.44 M $17.94 M $4.60 M $4.54 M $4.44 M $1.74 M $1.23 M $736.91 K $736.40 K $545.72 K
Link